CI
IZRL icon

CX Institutional’s ARK Israel Innovative Technology ETF IZRL Stock Holding History

CX Institutional’s Portfolio IZRL Stock Details IZRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$34K Hold
1,206
– – ﹤0.01% 1098
2026
Q2 		$37K Hold
1,206
– – ﹤0.01% 1032
2026
Q1 		$32K Hold
1,206
– – ﹤0.01% 1039
2025
Q4 		$36K Sell
1,206
-468
-28% -$13.7K ﹤0.01% 1021
2025
Q3 		$49K Hold
1,674
– – ﹤0.01% 938
2025
Q2 		$45K Hold
1,674
– – ﹤0.01% 867
2025
Q1 		$36K Buy
+1,674
New +$39.2K ﹤0.01% 882

Other funds holding IZRL

IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
GBT
Grove Bank & Trust Miami, Florida $1.01B AUM 19.76% 1-Year Est. Return

CX Institutional's IZRL Position: Q3 2026 in Review

CX Institutional held its ARK Israel Innovative Technology ETF (IZRL) position steady in Q3 2026 at 1,206 shares worth $34K. The position accounts for ﹤0.01% of the portfolio, ranked #1098.

CX Institutional first reported a position in IZRL in Q1 2025 and has held it in 7 quarters since. The position peaked at $49K in Q3 2025. 5 funds tracked by Wall St. Rank hold IZRL as of Q3 2026.

  • CX Institutional held 1,206 shares of ARK Israel Innovative Technology ETF worth $34K as of Q3 2026.
  • CX Institutional left its ARK Israel Innovative Technology ETF share count unchanged in Q3 2026.
  • ARK Israel Innovative Technology ETF made up ﹤0.01% of CX Institutional's portfolio in Q3 2026, its #1098 holding.
  • CX Institutional first reported a position in ARK Israel Innovative Technology ETF in Q1 2025 and has held it in 7 quarters since.
  • CX Institutional's ARK Israel Innovative Technology ETF position peaked at $49K in Q3 2025.
  • 5 funds tracked by Wall St. Rank held ARK Israel Innovative Technology ETF as of Q3 2026.

Based on CX Institutional's 13F filing for Q3 2026, filed 2 Oct 2026.